- freely available
Development of a Taste-Masked Orodispersible Film Containing Dimenhydrinate
AbstractOrodispersible dosage forms are promising new approaches for drug delivery. They enable an easy application, as there is no need to drink high amounts of liquids or swallow large solid dosage forms. The aim of the study was to develop an orodispersible film (ODF) as an alternative to tablets, syrups or suppositories for the treatment of vomiting and nausea, especially for the pediatric population. Formulations were investigated by X-ray diffraction, scanning electron and polarized light microscopy. Additionally, two commercially available electronic taste sensing systems were used to investigate the applied taste-masking strategies. Results obtained from X-ray-diffraction and polarized light microscopy showed no recrystallization of dimenhydrinate in the formulation when cyclodextrin or maltodextrin were used as solubilizing and complexing agent. All ODFs showed fast disintegration depending on the characterization method. In order to get taste information, the dimenhydrinate formulations were analytically compared to pure drug and drug-free formulations by electronic tongues. Results obtained from both systems are comparable and were used together for the first time. It was possible to develop an ODF of dimenhydrinate that is fast disintegrating even in small volumes of liquid. Furthermore, in vitro taste assessment by two electronic tongues revealed taste-masking effects by the excipients.
Share & Cite This Article
Export to BibTeX | EndNote
MDPI and ACS Style
Preis, M.; Pein, M.; Breitkreutz, J. Development of a Taste-Masked Orodispersible Film Containing Dimenhydrinate. Pharmaceutics 2012, 4, 551-562.View more citation formats
Preis M, Pein M, Breitkreutz J. Development of a Taste-Masked Orodispersible Film Containing Dimenhydrinate. Pharmaceutics. 2012; 4(4):551-562.Chicago/Turabian Style
Preis, Maren; Pein, Miriam; Breitkreutz, Jörg. 2012. "Development of a Taste-Masked Orodispersible Film Containing Dimenhydrinate." Pharmaceutics 4, no. 4: 551-562.